Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters
- Study Title
- A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
- Teva Identifier
- DSG-HSP-201
- ClinicalTrials.gov Identifier
- NCT01388491
- Study Status
- Completed
- Trial Condition(s)
- Hemostasis | Oral Contraceptive
- Interventions
- Drug: desogestrel/ethinyl estradiol and ethinyl estradiol | Drug: desogestrel/ethinyl estradiol
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female
- Age group
- Adult
- Age Range
- 18 Years to 40 Years
- Trial Duration
- 10/01/2011 - 09/01/2012
- Phase
- Phase 2
